Adoptive T <sub>reg</sub> therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome

Wentao Zhang(Zhejiang University), Yingxin Chen(Hangzhou Dianzi University), Zhengjie Zhao(Zhejiang University), Hanqi Zheng(Zhejiang University), Shenqiang Wang(Zhejiang University), Ziyan Liao(Zhejiang University), Tao Sheng(Zhejiang University), Sheng Zhao(Zhejiang University), Wenhui Hou(Zhejiang University), Xinmin Yu(Zhejiang University), Fang He(Second Affiliated Hospital of Zhejiang University), Jicheng Yu(Sir Run Run Shaw Hospital), Yuqi Zhang(Second Affiliated Hospital of Zhejiang University), Zhen Gu(Sir Run Run Shaw Hospital)
Science Advances
May 17, 2023
Cited by 74Open Access
Full Text

Abstract

Regulatory T (T reg ) cells underlie multiple autoimmune disorders and potentialize an anti-inflammation treatment with adoptive cell therapy. However, systemic delivery of cellular therapeutics often lacks tissue targeting and accumulation for localized autoimmune diseases. Besides, the instability and plasticity of T reg cells also induce phenotype transition and functional loss, impeding clinical translation. Here, we developed a perforated microneedle (PMN) with favorable mechanical performance and a spacious encapsulation cavity to support cell survival, as well as tunable channels to facilitate cell migration for local T reg therapy of psoriasis. In addition, the enzyme-degradable microneedle matrix could release fatty acid in the hyperinflammatory area of psoriasis, enhancing the T reg suppressive functions via the fatty acid oxidation (FAO)–mediated metabolic intervention. T reg cells administered through PMN substantially ameliorated psoriasis syndrome with the assistance of fatty acid–mediated metabolic intervention in a psoriasis mouse model. This tailorable PMN could offer a transformative platform for local cell therapy to treat a variety of diseases.


Related Papers

No related papers found

Powered by citation graph analysis